184 related articles for article (PubMed ID: 37695101)
1. Approaches for timeline reductions in pathogenesis studies using genetically modified mice.
Skavicus S; Heaton NS
Microbiol Spectr; 2023 Sep; 11(5):e0252123. PubMed ID: 37695101
[TBL] [Abstract][Full Text] [Related]
2. Genotyping Protocols for Genetically Engineered Mice.
Limaye A; Cho K; Hall B; Khillan JS; Kulkarni AB
Curr Protoc; 2023 Nov; 3(11):e929. PubMed ID: 37984376
[TBL] [Abstract][Full Text] [Related]
3. [Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].
Wang YD; Liang QF; Li ZY; Zhao CY
Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):860-864. PubMed ID: 30616324
[TBL] [Abstract][Full Text] [Related]
4. Applications of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) as a Genetic Scalpel for the Treatment of Cancer: A Translational Narrative Review.
Mondal R; Brahmbhatt N; Sandhu SK; Shah H; Vashi M; Gandhi SK; Patel P
Cureus; 2023 Dec; 15(12):e50031. PubMed ID: 38186450
[TBL] [Abstract][Full Text] [Related]
5. Generation of Mouse Model (KI and CKO) via Easi-CRISPR.
Shola DTN; Yang C; Han C; Norinsky R; Peraza RD
Methods Mol Biol; 2021; 2224():1-27. PubMed ID: 33606203
[TBL] [Abstract][Full Text] [Related]
6. Construction of genome-wide protein tagging cell and mouse libraries.
Jiang J; Zhao AQ; Xie T; Chen SW; Li JS
Yi Chuan; 2021 Jul; 43(7):704-714. PubMed ID: 34284985
[TBL] [Abstract][Full Text] [Related]
7. Generation of novel Il2rg-knockout mice with clustered regularly interspaced short palindromic repeats (CRISPR) and Cas9.
Byambaa S; Uosaki H; Hara H; Nagao Y; Abe T; Shibata H; Nureki O; Ohmori T; Hanazono Y
Exp Anim; 2020 Apr; 69(2):189-198. PubMed ID: 31801915
[TBL] [Abstract][Full Text] [Related]
8. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
[TBL] [Abstract][Full Text] [Related]
9. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
Mashimo T
Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
[TBL] [Abstract][Full Text] [Related]
10. A CRISPR-Assisted Nonhomologous End-Joining Strategy for Efficient Genome Editing in Mycobacterium tuberculosis.
Yan MY; Li SS; Ding XY; Guo XP; Jin Q; Sun YC
mBio; 2020 Jan; 11(1):. PubMed ID: 31992616
[TBL] [Abstract][Full Text] [Related]
11. The Impact of CRISPR/Cas9 Technology on Cardiac Research: From Disease Modelling to Therapeutic Approaches.
Motta BM; Pramstaller PP; Hicks AA; Rossini A
Stem Cells Int; 2017; 2017():8960236. PubMed ID: 29434642
[TBL] [Abstract][Full Text] [Related]
12. Mouse Models for Drug Discovery. Can New Tools and Technology Improve Translational Power?
Zuberi A; Lutz C
ILAR J; 2016 Dec; 57(2):178-185. PubMed ID: 28053071
[TBL] [Abstract][Full Text] [Related]
13. Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Gene Editing Technique in Xenotransplantation.
Naeimi Kararoudi M; Hejazi SS; Elmas E; Hellström M; Naeimi Kararoudi M; Padma AM; Lee D; Dolatshad H
Front Immunol; 2018; 9():1711. PubMed ID: 30233563
[TBL] [Abstract][Full Text] [Related]
14. Rapid Generation of Long Noncoding RNA Knockout Mice Using CRISPR/Cas9 Technology.
Hansmeier NR; Widdershooven PJM; Khani S; Kornfeld JW
Noncoding RNA; 2019 Jan; 5(1):. PubMed ID: 30678101
[TBL] [Abstract][Full Text] [Related]
15. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
Wang P
mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
[No Abstract] [Full Text] [Related]
16. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
[TBL] [Abstract][Full Text] [Related]
17. Use of CRISPR/Cas9 for the Modification of the Mouse Genome.
Klimke A; Güttler S; Kuballa P; Janzen S; Ortmann S; Flora A
Methods Mol Biol; 2019; 1953():213-230. PubMed ID: 30912024
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Based Gene Editing: a Modern Approach for Study and Treatment of Cancer.
Talukder P; Chanda S; Chaudhuri B; Choudhury SR; Saha D; Dash S; Banerjee A; Chatterjee B
Appl Biochem Biotechnol; 2023 Sep; ():. PubMed ID: 37737443
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
Vermersch E; Jouve C; Hulot JS
Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
[TBL] [Abstract][Full Text] [Related]
20. CRISPR somatic genome engineering and cancer modeling in the mouse pancreas and liver.
Kaltenbacher T; Löprich J; Maresch R; Weber J; Müller S; Oellinger R; Groß N; Griger J; de Andrade Krätzig N; Avramopoulos P; Ramanujam D; Brummer S; Widholz SA; Bärthel S; Falcomatà C; Pfaus A; Alnatsha A; Mayerle J; Schmidt-Supprian M; Reichert M; Schneider G; Ehmer U; Braun CJ; Saur D; Engelhardt S; Rad R
Nat Protoc; 2022 Apr; 17(4):1142-1188. PubMed ID: 35288718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
